Is Idexx Laboratories, Inc (NASDAQ: IDXX) Still On The Rise?

After Hours

There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.

Stocks Info

This NASDAQ-listed company operates within the Diagnostics & Research industry segment, falling under the Healthcare sector. The current market capitalization of Idexx Laboratories, Inc is $37.40B. A total of 0.84 million shares were traded on the day, compared to an average of 660.47K shares.

In the most recent transaction, FENNELL GEORGE sold 9,986 shares of IDXX for 462.53 per share on Feb 10 ’25. After the transaction, the Executive Vice President now owns 8,176 company shares. In a previous transaction on Feb 10 ’25, FENNELL GEORGE bought 9,966 shares at 463.46 per share.

Among the insiders who sold shares, SZOSTAK M ANNE disposed of 3,000 shares on Feb 07 ’25 at a per-share price of $465.94. This resulted in the Director holding 3,061 shares of IDXX after the transaction. In another insider transaction, Margaret Anne Szostak bought 3,000 shares at $460.56 per share on Feb 07 ’25.

Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, IDXX has a high of $583.39 and a low of $398.50.

As of this writing, IDXX has an earnings estimate of $2.85 per share for the current quarter. EPS was calculated based on a consensus of 11.0 estimates, with a high estimate of $2.96 per share and a lower estimate of $2.77.

Balance Sheet Annually/Quarterly

In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. IDXX’s latest balance sheet shows that the firm has $144.45M in Cash & Short Term Investments as of fiscal 2021. There were $1.03B in debt and $763.58M in liabilities at the time. Its Book Value Per Share was $19.55, while its Total Shareholder’s Equity was $689.99M.

Analysts Opinion

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for IDXX is Buy with a score of 4.18.

Most Popular

Related Posts